272 related articles for article (PubMed ID: 35029034)
1. Biologic and targeted therapeutics in vitiligo.
Karagaiah P; Schwartz RA; Lotti T; Wollina U; Grabbe S; Goldust M
J Cosmet Dermatol; 2023 Jan; 22(1):64-73. PubMed ID: 35029034
[TBL] [Abstract][Full Text] [Related]
2. Repigmentation in vitiligo using janus kinase (JAK) inhibitors with phototherapy: systematic review and Meta-analysis.
Phan K; Phan S; Shumack S; Gupta M
J Dermatolog Treat; 2022 Feb; 33(1):173-177. PubMed ID: 32096671
[TBL] [Abstract][Full Text] [Related]
3. A review of JAK and IL-23 inhibitors to treat vitiligo.
Lee H; Cowan TL; Daniel BS; Murrell DF
Australas J Dermatol; 2023 May; 64(2):204-212. PubMed ID: 36810815
[TBL] [Abstract][Full Text] [Related]
4. The use of Janus kinase inhibitors and narrowband ultraviolet B combination therapy in non-segmental vitiligo.
Yousefian F; Yadlapati S; Browning JC
J Cosmet Dermatol; 2023 Mar; 22(3):1105-1107. PubMed ID: 36440703
[TBL] [Abstract][Full Text] [Related]
5. Vitiligo: an update on systemic treatments.
Searle T; Al-Niaimi F; Ali FR
Clin Exp Dermatol; 2021 Mar; 46(2):248-258. PubMed ID: 33350506
[TBL] [Abstract][Full Text] [Related]
6. The Use of Janus Kinase Inhibitors in Vitiligo: A Review of the Literature.
Relke N; Gooderham M
J Cutan Med Surg; 2019; 23(3):298-306. PubMed ID: 30902022
[TBL] [Abstract][Full Text] [Related]
7. JAK inhibitors in vitiligo: what they hit and what they miss - an immunopathogenesis based exposition of existing evidence.
Sardana K; Muddebihal A; Khurana A
Expert Rev Clin Pharmacol; 2023; 16(12):1221-1227. PubMed ID: 37982238
[TBL] [Abstract][Full Text] [Related]
8. Vitiligo: Pathogenesis and New and Emerging Treatments.
Perez-Bootello J; Cova-Martin R; Naharro-Rodriguez J; Segurado-Miravalles G
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139134
[TBL] [Abstract][Full Text] [Related]
9. Vitiligo: An Updated Narrative Review.
Leung AKC; Lam JM; Leong KF; Hon KL
Curr Pediatr Rev; 2021; 17(2):76-91. PubMed ID: 33302860
[TBL] [Abstract][Full Text] [Related]
10. Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis.
Li R; Qiao M; Wang X; Zhao X; Sun Q
Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):22-31. PubMed ID: 27696531
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of 308-nm excimer laser/light (EL) and topical agent combination therapy versus EL monotherapy for vitiligo: A systematic review and meta-analysis of randomized controlled trials (RCTs).
Bae JM; Hong BY; Lee JH; Lee JH; Kim GM
J Am Acad Dermatol; 2016 May; 74(5):907-15. PubMed ID: 26785803
[TBL] [Abstract][Full Text] [Related]
12. Updates on Potential Therapeutic Approaches for Vitiligo: Janus Kinase Inhibitors and Biologics.
Pala V; Ribero S; Quaglino P; Mastorino L
J Clin Med; 2023 Dec; 12(23):. PubMed ID: 38068541
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of traditional and surgical treatment modalities in segmental vitiligo: A review article.
Khalili M; Amiri R; Mohammadi S; Iranmanesh B; Aflatoonian M
J Cosmet Dermatol; 2022 Jun; 21(6):2360-2373. PubMed ID: 35253324
[TBL] [Abstract][Full Text] [Related]
14. Vitiligo Treatments: Review of Current Therapeutic Modalities and JAK Inhibitors.
Cunningham KN; Rosmarin D
Am J Clin Dermatol; 2023 Mar; 24(2):165-186. PubMed ID: 36715849
[TBL] [Abstract][Full Text] [Related]
15. Emerging drugs for the treatment of vitiligo.
Karagaiah P; Valle Y; Sigova J; Zerbinati N; Vojvodic P; Parsad D; Schwartz RA; Grabbe S; Goldust M; Lotti T
Expert Opin Emerg Drugs; 2020 Mar; 25(1):7-24. PubMed ID: 31958256
[No Abstract] [Full Text] [Related]
16. Expert Recommendations on Use of Topical Therapeutics for Vitiligo in Pediatric, Adolescent, and Young Adult Patients.
Renert-Yuval Y; Ezzedine K; Grimes P; Rosmarin D; Eichenfield LF; Castelo-Soccio L; Huang V; Desai SR; Walsh S; Silverberg JI; Paller AS; Rodrigues M; Weingarten M; Narla S; Gardner J; Siegel M; Ibad S; Silverberg NB
JAMA Dermatol; 2024 Apr; 160(4):453-461. PubMed ID: 38477910
[TBL] [Abstract][Full Text] [Related]
17. Home phototherapy in vitiligo.
Mohammad TF; Silpa-Archa N; Griffith JL; Lim HW; Hamzavi IH
Photodermatol Photoimmunol Photomed; 2017 Sep; 33(5):241-252. PubMed ID: 28620923
[TBL] [Abstract][Full Text] [Related]
18. Topical ruxolitinib: A new treatment for vitiligo.
Tavoletti G; Avallone G; Conforti C; Roccuzzo G; Maronese CA; Mattioli MA; Quaglino P; Zalaudek I; Marzano AV; Ribero S; Alberti-Violetti S
J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2222-2230. PubMed ID: 37147856
[TBL] [Abstract][Full Text] [Related]
19. Effect of topical calcineurin inhibitors as monotherapy or combined with phototherapy for vitiligo treatment: a meta-analysis.
Dang YP; Li Q; Shi F; Yuan XY; Liu W
Dermatol Ther; 2016; 29(2):126-33. PubMed ID: 26460804
[TBL] [Abstract][Full Text] [Related]
20. Janus Kinase Inhibitors in the Treatment of Vitiligo: A Review.
Qi F; Liu F; Gao L
Front Immunol; 2021; 12():790125. PubMed ID: 34868078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
